We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current 2M6 market cap is 113.73B. The company's latest EPS is USD 2.8675 and P/E is 32.09.
| Year End 26 April 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 28.91B | 30.12B | 31.69B | 31.39B | 32.36B |
| Operating Income | 4.66B | 4.32B | 5.84B | 5.49B | 5.15B |
| Net Income | 4.79B | 3.61B | 5.04B | 3.76B | 3.68B |
| Year End 26 April 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 90.69B | 93.08B | 90.98B | 90.95B | 89.98B |
| Total Liabilities | 39.82B | 41.48B | 38.26B | 39.28B | 39.56B |
| Total Equity | 50.87B | 51.6B | 52.72B | 51.67B | 50.42B |
| Year End 26 April 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 7.23B | 6.24B | 7.35B | 6.04B | 6.79B |
| Investing | -3.2B | -2.87B | -1.66B | -3.49B | -2.37B |
| Financing | -4.2B | -4.14B | -5.34B | -4.96B | -4.45B |
| Market Cap | 113.73B |
| Price to Earnings Ratio | 32.09 |
| Price to Sales Ratio | 3.65 |
| Price to Cash Ratio | 91.9 |
| Price to Book Ratio | 2.34 |
| Dividend Yield | 3.28% |
| Shares Outstanding | 1.28B |
| Average Volume (1 week) | 3.54k |
| Average Volume (1 Month) | 5.63k |
| 52 Week Change | 14.44% |
| 52 Week High | 90.59 |
| 52 Week Low | 15.5989 |
| Spread (Intraday) | 0.27 (0.3%) |
| Company Name | Medtronic Plc |
| Address |
20 lower dublin D02 XH02 |
| Website | https://www.medtronic.com |
| Industry | electromedical apparatus (3845) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
